Related Experiment Videos
Polymeric prodrugs
K Hoste1, K De Winne, E Schacht
1Department of Organic Chemistry, Ghent University, Krijgslaan 281 (S4bis), 9000 Gent, Belgium.
International Journal of Pharmaceutics
|May 26, 2004
Summary
Polymeric prodrugs, designed using Ringsdorf
Area of Science:
- Polymer Chemistry
- Medicinal Chemistry
- Drug Delivery
Background:
- The 1975 model by Prof. H. Ringsdorf established the foundation for designing polymeric prodrugs.
- This model integrated crucial chemical and biological considerations for effective prodrug development.
- Research in polymeric prodrugs has evolved significantly since the initial model.
Purpose of the Study:
- To review key properties discovered in polymeric prodrug design.
- To highlight advancements and new objectives in the field.
- To detail recent findings, such as the immunoprotective ability of polymeric prodrugs.
Main Methods:
- Review of established properties of polymeric prodrugs.
- Discussion of drug action prolongation.
- Analysis of controlled drug release mechanisms.
- Exploration of passive tumor targeting via the Enhanced Permeability and Retention (EPR) effect.
- Examination of alterations in body distribution and cellular uptake.
- Detailed description of immunoprotective properties.
Main Results:
- Key properties include prolonged drug action and controlled release.
- Polymeric prodrugs facilitate passive tumor accumulation through the EPR effect.
- Significant alterations in drug distribution and cell uptake are observed.
- Emerging properties, like immunoprotection, expand the utility of these conjugates.
Conclusions:
- Polymeric prodrugs offer versatile strategies for drug delivery optimization.
- The field continues to uncover novel properties and applications.
- Recent discoveries, such as immunoprotection, present new therapeutic avenues.